期刊文献+

人促肾上腺皮质激素释放因子Ⅰ型受体EC1片段在原核系统中的可溶性表达 被引量:1

Soluble Expression of EC1 Fragment of Human Corticotropin-Releasing Factor Receptor Ⅰ in Prokaryotic System
下载PDF
导出
摘要 目的:研究人促肾上腺皮质激素释放因子Ⅰ型受体(hCRFR1)EC1区蛋白片段在原核表达系统中可溶性表达的影响因素。方法:以pcDNA3.1-hCRFR1全长质粒为模板,PCR扩增EC1区分别编码118和88个氨基酸残基(分别对应融合蛋白GST-EC1118和GST-EC188)的片段,将其插入pGEX-4T2载体,转化大肠杆菌BL21(DE3),用IPTG诱导目标蛋白表达;采用GSTrap FF亲和纯化柱对目标蛋白进行纯化,并用Western印迹证实。结果:与GST-EC1118相比,GST-EC188可溶性表达增加,为下一步hCRFR1相关研究的开展奠定了基础。结论:hCRFR1的EC1区M1~N19及N108~V118两个片段影响该区域在原核系统中表达的可溶性,推测可能与富含疏水性氨基酸有关。 Objective: To study the factors that affect soluble expression of human corticotropin-releasing factor receptorⅠ(hCRFR1) EC1 fragment in prokaryotic system.Methods: The sequences encoding 118-and 88-amino acid of hCRFR1 EC1 region(corresponding to fusion protein GST-EC1 118 and GST-EC1 88,respectively) were ampli-fied by PCR using pcDNA3.1-hCRFR1 as template and were then inserted into pGEX-4T2 vector.The expression of target proteins was induced by IPTG by employing Escherichia coli BL21(DE3) as host cells.After purified with GSTrap FF affinity chromatography column,the proteins were identified using anti-GST antibody.Results: Compared to GST-EC1 118,soluble expression of GST-EC1 88 was increased,which provides basis for further research of hCRFR1.Conclusion: The fragments M 1 ~N 19 and N 108 ~V 118 affect solubility of hCRFR1 EC1 region in prokaryotic expression system,which may be associated with the abundant hydrophobic amino acids in this region.
出处 《生物技术通讯》 CAS 2011年第5期675-678,682,共5页 Letters in Biotechnology
基金 国家重点基础研究发展计划(2007CB512307)
关键词 人促肾上腺皮质激素释放因子Ⅰ型受体 EC1 可溶性 原核表达 human corticotropin-releasing factor receptorⅠ EC1 solubility prokaryotic expression
  • 相关文献

参考文献20

  • 1Spiess J,Rivier J,Rivier C,et al.Primary structure of corticotropmi-releasing factor from ovine hypothalamus[J].Med Sci,1981,78(10):6517-6521.
  • 2Heinrichs S C,Koob G F.Corticotropin-releasing factor in brain:a role in activation,arousal,and affect regulation[J].J Pharmacol Exp Ther,2004,311:427-440.
  • 3Richard L,Hauger V R,Brauns O.Corticotropin releasing factor(CRF) receptor signaling in the central nervous system:new molecular targets[J].CNS Neurol Disord Drug Targets,2006,5(4):453-479.
  • 4Tache Y,Martinez V,Wang L,et al.CRF1 receptor signaling path-ways are involved in stress-related alterations of colonic function and viscerosensitivity:implications for irritable bowel syndrome[J].Br J Pharmacol,2004,141(8):1321-1330.
  • 5Porcher C,Juhem A,Peinnequin A,et al.Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine[J].Physiol Gastrointest Liver Physiol,2005,88(5):1091-1103.
  • 6Karteris E,Goumenou A,Koumantakis E,et al.Reduced expression of CRH-R1α in human preeclamptic and IUGR placenta[J].J Clin Endocrinol Metab,2003,88:1363-1370.
  • 7Graziani G,Ferrandina G,Pozzoli G,et al.Corticotropin-releasing hormone receptor-1 in human endometrial cancer[J].Oncol Rep,2006,15(2):375-379.
  • 8Timpl P,Spanagel R,Sillaber I,et al.Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1[J].Nat Genet,1998,19:162-166.
  • 9Smith G W,Aubry J M,Dellu F,et al.Corticotropin releasing factor receptor 1-deficient mice display deceased anxiety,impaired stress response,and aberrant neuroendocrine development[J].Neuron,1998,20:1093-1102.
  • 10Hiroi N,Wong M L,Licinio J,et al.Expression of corticotropin releasing hormone receptors type Ⅰ and type Ⅱ mRNA in suicide victims and controls[J].Mol Psychiatry,2001,6:540-546.

二级参考文献10

  • 1KiethaberT, Rudolph R, Kohler H, et al.BioTechnologh, 1991,9 : 825 - 829.
  • 2Derman AI, Prinz W,Belin D,et al.Science, 1993,262:1744 - 1747.
  • 3Misawa S, Kunagai I.Biopolymer, 1999,51: 297 - 307.
  • 4White C B, Chen Q, Kenyon Gl, et al. J B io Chem, 1995,270:12990 - 12994.
  • 5Khan RH,Appa Rao KBC,Eshwari ANS,et al.Biotechnol Prog, 1998,14 : 722 - 728.
  • 6Lille H, Schwarz E, Rudolph R.Curr Opin Biotechnol, 1998,9(5 ): 497 - 501.
  • 7Rudolpg R, Lilie H.FASEBJ, 1996,10( 1 ) : 49 - 56.
  • 8Wetalaufer DB, Xie Y.Protein Sci, 1995,4(8 ) : 1535 - 1543.
  • 9Rozema D, Gellman SH.Biochemistry, 1996,35 ( 49 ) : 15760 - 15771.
  • 10高永贵,关怡新,姚善泾.包涵体蛋白的变复性研究[J].科技通报,2003,19(1):10-15. 被引量:28

共引文献24

同被引文献18

  • 1张敏娟,张庆瑜.促肾上腺皮质激素释放因子及其受体的研究[J].国际病理科学与临床杂志,2006,26(2):162-165. 被引量:9
  • 2曾纯,严灿,徐志伟,吴丽丽.促肾上腺皮质激素释放激素受体在应激反应中的作用研究[J].中国药理学通报,2006,22(5):517-520. 被引量:8
  • 3Grammatopoulos DK, Chrousos GP. Functional characteristicsof CRH receptors and potential clinical applications ofCRH-receptor antagonists [ J ] ? Trends Endocrinol Metab,2002, 13 (10) : 436444.
  • 4Kiank C, Tache Y, Larauche M. Stress-related modulationof inflammation in experimental models of bowel diseaseand post-infectious irritable bowel syndrome : role ofcorticotropin-releasing factor receptors [ J ] . Brain BehavImmun, 2010,24 (1) ; 41^8.
  • 5Margolis KG, Gershon MD. Neuropeptides and inflammatorybowel disease [ J ]. Curr Opin Gastroenterol,2009,25(6) ; 503-511.
  • 6Aguilera G,Nikodemova M, Wynn PC, et al. Corticotropinreleasing hormone receptors : two decades later [ J ].Peptides, 2004, 25 (3) : 319-329.
  • 7Bale TL, Contarino A, Smith GW, et al. Mice deficient forcorticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress [ J ]. NatGenet, 2000,24 (4) : 410414.
  • 8Coste SC,Kesterson RA,Heldwein KA, et al. Abnormaladaptations to stress and impaired cardiovascular function inmice lacking corticotropin-releasing hormone receptor-2[J]. Nat Genet, 2000,24 (4) : 403409.
  • 9Stengel A, Tach6 Y. Corticotropin-releasing factor signalingand visceral response to stress [ J ] ? Exp Biol Med(Maywood), 2010,235 (10) : 1168-1178.
  • 10Agelaki S, Tsatsanis C, Gravanis A, et al. Corticotropin-releasing hormone augments proinflammatory cytokineproduction from macrophages in vitro and in lipopoly-saccharide-induced endotoxin shock in mice [ J ]. InfectImmun, 2002,70 (11) : 6068-6074.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部